Eric Hemberg
Family Medicine · Opelika, ALNPI 1992738926
Payments from drug & device makers
Across 463 payments — averaging $17.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$825
- Novo Nordisk$697
- Pfizer$674
- Amarin Pharma, Inc.$420
- Merck$419
- plus $3K from 40 others
What the payments were for
- Food & beverage$7,963100%
- Education$370%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$250
- Vascepa$223
- TRELEGY ELLIPTA$213
- Inspire$135
- NEXLIZET$125
- NEXLETOL$125
- STEGLATRO$122
- FREESTYLE LIBRE 3$121
- NUCALA$117
- RYBELSUS$104
How this compares
$8,000 in reported general payments places this provider in the 85th percentile of 1,680 family medicine providers in Alabama.
Other family medicine in Opelika
- Sunil SharmaOpelika$17K
- Michael VaughnBirmingham$9.9M
- William NixonGuntersville$7.1M
- Randall QuinnCullman$5.4M
- Matthew CaldwellAthens$4.1M
- Michael CarterHuntsville$3.4M
- Howard RubensteinSaraland$3.3M
- Randle MiddletonHuntsville$3.3M
- Aaron KarrSheffield$3.1M
- Nidal MorrarFoley$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.